1. Inicio
  2. Publicaciones
  3. Precision Medicine in Patients With Resistant Hypertension and Obstructive Sleep Apnea Blood Pressure Response to Continuous Positive Airway Pressure Treatment

Precision Medicine in Patients With Resistant Hypertension and Obstructive Sleep Apnea Blood Pressure Response to Continuous Positive Airway Pressure Treatment

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Sanchez-de-la-Torre, M
  • Khalyfa, A
  • Sanchez-de-la-Torre, A
  • Martinez-Alonso, M
  • Barcelo, A
  • Lloberes, P
  • Campos-Rodriguez, F
  • Capote, F
  • Diaz-de-Atauri, MJ
  • Somoza, M
  • Gonzalez, M
  • Masa, JF
  • Gozal, D
  • Barbe, F
  • Spanish Sleep Network

Grupos

Abstract

BACKGROUND In patients with resistant hypertension (RH) and obstructive sleep apnea (OSA), the blood pressure response to continuous positive airway pressure (CPAP) treatment is highly variable and could be associated with differential micro-ribonucleic acid (miRNA) profiles. Currently, no available methods exist to identify patients who will respond favorably to CPAP treatment. OBJECTIVES The aim of this study was to identify plasma miRNA profiles that predict blood pressure responses to CPAP treatment. METHODS Cardiovascular system-focused circulating miRNA expression was evaluated in plasma samples using an 84-miRNA array among patients with RH and OSA at baseline and after 3 months of adherent CPAP use. Pathway analysis and miRNA target gene enrichment were performed in silico. Plasma levels of peptides and hormones related to cardiovascular function were also measured. RESULTS The OSA responder group exhibited blood pressure decreases exceeding the observed median (>4.5 mm Hg) after CPAP, which were not present in the nonresponder group (<= 4.5 mm Hg) (p < 0.01). Three miRNAs provided a discriminatory predictive model for such a favorable blood pressure response to CPAP (area under the curve: 0.92; p = 0.01). Additionally, CPAP treatment significantly altered a total of 47 plasma miRNAs and decreased aldosterone-to-renin ratios in the responder group (p = 0.016) but not in the nonresponder group. CONCLUSIONS A singular pre-CPAP treatment cluster of 3 plasma miRNAs predicts blood pressure responses to CPAP treatment in patients with RH and OSA. CPAP treatment is accompanied by changes in cardiovascular system-related miRNAs that may potentially influence the risk for cardiovascular disease among patients with OSA and RH. (Effect of Continuous Positive Airway Pressure [CPAP] Treatment in the Control of Refractory Hypertension; NCT00616265) (C) 2015 by the American College of Cardiology Foundation.

Datos de la publicación

ISSN/ISSNe:
0735-1097, 1558-3597

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY  ELSEVIER SCIENCE INC

Tipo:
Article
Páginas:
1023-1032
PubMed:
26314530
Factor de Impacto:
10,686 SCImago ℠
Cuartil:
Q1 SCImago ℠

Citas Recibidas en Web of Science: 137

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • cardiovascular disease; miRNA; personalized medicine; sleep apnea

Campos de Estudio

Proyectos y Estudios Clínicos

INTENSIFICACION DR. MIGUEL MARTINEZ GARCIA

Investigador Principal: MIGUEL ÁNGEL MARTÍNEZ GARCÍA

INT11/037 . 2012

ASOCIACION ENTRE TRASTORNOS RESPIRATORIOS DEL SUEÑO Y TASA DE CRECIMIENTO DEL MELANOMA CUTANEO

Investigador Principal: MIGUEL ÁNGEL MARTÍNEZ GARCÍA

PI12/01363 . INSTITUTO DE SALUD CARLOS III . 2013

EFECTO DEL TRATAMIENTO CON CPAP SOBRE LAS CIFRAS TENSIONALES EN PACIENTES CON HIPERTENSION ARTERIAL REFRACTARIA. ESTUDIO MULTICENTRICO Y ALEATORIZADO. ESTUDIO HIPARCO

Investigador Principal: MIGUEL ÁNGEL MARTÍNEZ GARCÍA

PI09/01647 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2010

INTENSIFICACION DR. MIGUEL ANGEL MARTINEZ GARCIA

Investigador Principal: MIGUEL ÁNGEL MARTÍNEZ GARCÍA

INT14/00003 . INSTITUTO DE SALUD CARLOS III . 2015

Cita

Compartir